FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention refers to pharmaceutical industry, namely to an oligopeptide-based composition which suppresses replication of influenza A virus. A composition for treating influenza on the basis of oligopeptide, suppressing replication of influenza A virus, sequence 6–14 of protein of polymer complex PB1 of influenza virus, acetylated by N-terminal and amidated by C-terminal, formula Ac-Thr-Leu-Leu-Phe-Leu-Lys-Val-Pro-Ala-NH2, which additionally contains dimethylsulphoxide, ethanol and water, taken in certain amounts.
EFFECT: disclosed oligopeptide-based composition is stable and has high solubility of the oligopeptide.
1 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL PEPTIDE SUPPRESSING REPLICATION OF INFLUENZA VIRUS | 2012 |
|
RU2492178C1 |
| RECOMBINANT STRAIN OF A/PR8-NS124-Luc INFLUENZA VIRUS AND METHOD FOR EVALUATING POST-VACCINAL NEUTRALIZING ANTIBODIES USING BIOLUMINESCENT DETECTION | 2019 |
|
RU2759054C2 |
| 6,13,13-TRIMETHYL-6,8,9,12-TETRAHYDRO-6,9-METHANOSEPINO[2,1-B]HINAZOLIN-10(7H)-ONE AS THE INHIBITOR OF INFLUENZA VIRUSES | 2017 |
|
RU2664331C1 |
| AGENT REPRESENTING GLYCYRRHIZIC ACID AMIDE WITH 5-AMINOURACIL SHOWING ANTIVIRAL ACTIVITY ON A/H1N1 INFLUENZA VIRUS | 2014 |
|
RU2568849C9 |
| METHOD OF TREATING INFECTIOUS DISEASES CAUSED BY INFLUENZA VIRUS WITH TYPE H1N1 SURFACE ANTIGEN AND THERAPEUTIC AGENT FOR TREATING INFECTIOUS DISEASES CAUSED BY INFLUENZA VIRUS WITH TYPE H1N1 SURFACE ANTIGEN | 2010 |
|
RU2527688C2 |
| CULTIVATED HYBRID CELL STRAIN OF MOUSE Mus. Musculus-1E7 PRODUCER OF MONOCLONAL ANTIBODY IMMUNORESPONSIVE TO HAEMAGGLUTININ PROTEIN OF PANDEMIC INFLUENA VIRUS A/IIV-Moscow/01/09(H1N1)sw1 | 2011 |
|
RU2457243C1 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF BASIDIOMYCETE Coprinus comatus | 2015 |
|
RU2584751C1 |
| ANTIVIRAL COMPOUND OF MULTIPLE ACTION, ITS COMPOSITION AND METHOD OF TREATING VIRAL DISEASES | 2012 |
|
RU2597150C2 |
| USING 1,7,7-TRIMETHYLBICYCLO[2,2,1]HEPTAN-2-YLIDENE-AMINOETHANOL AS INFLUENZA VIRUS REPRODUCTION INHIBITOR | 2013 |
|
RU2530554C1 |
| (1S,3aR,4R,7aS)-N-(2,2,4,7a-TETRAMETHYLOCTAHYDRO-1,4-ETHANOINDENE-3a-YL)-ACETAMIDE APPLICATION AS A INFLUENZA VIRUS REPRODUCTION INHIBITOR | 2016 |
|
RU2616255C1 |
